BioMedVC
Verified
Location
Investor type
Current investment status
Website
Linkedin
Company address
Founding year
Twitter
Facebook
Switzerland
Investor type
Venture Capital
Current investment status
00 00 00
Website
https://biomedvc.com/en/biomedvc
00 00 00
Company address
Elisabethenanlage 11, Basel, 4051, Switzerland
Founding year
2002
00 00 00
00 00 00
| Criteria | Requirements | Match |
|---|---|---|
| Regions |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Impact Area |
00 00 00
|
|
| Stage |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Min. - Max. ticket size |
00 00 00
-
00 00 00
USD
|
00
|
| Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Min. revenue |
00 00 00
USD
|
00
|
| Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company Description
BioMedPartners is a healthcare-dedicated venture capital firm that specializes in providing financing to early-stage private companies and spin-offs within the biotechnology, emerging pharmaceutical, medical technology, and healthcare-related industries. With a focus on Switzerland, Germany, and neighboring EU countries, BioMedPartners manages several funds, including BioMedInvest I, II, and III, facilitating the development of innovative medical solutions. The firm emphasizes strategic investments in companies developing cutting-edge technologies and therapies aimed at improving patient outcomes in various healthcare sectors.
Highlights
Invest in private early- to mid-stage human Life Science companies
Focus on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux
Mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology.
Ready to raise better?
Start your free trial!